We are live on ! Find out more
NVAX icon

Novavax

252 hedge funds and large institutions have $540M invested in Novavax in 2022 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 79 increasing their positions, 64 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 64

15.57% more ownership

Funds ownership: 46.34%61.91% (+16%)

5% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 44

2% more call options, than puts

Call options by funds: $124M | Put options by funds: $121M

0% less funds holding

Funds holding: 253252 (-1)

18% less capital invested

Capital invested by funds: $657M → $540M (-$117M)

Holders
252
Holders Change
-1
Holders Change %
-0.4%
% of All Funds
4.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
46
Increased
79
Reduced
64
Closed
44
Calls
$124M
Puts
$121M
Net Calls
+$3M
Net Calls Change
+$27.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Rafferty Asset Management
26
Rafferty Asset Management
New York
$5.02M +$4.77M +270,106 +124%
National Bank of Canada
27
National Bank of Canada
Quebec, Canada
$4.97M +$8.5M +481,780 +36,088%
RCMU
28
Rokos Capital Management (UK)
United Kingdom
$4.92M +$8.82M +500,000 New
Barclays
29
Barclays
United Kingdom
$4.81M +$2M +113,247 +32%
Charles Schwab
30
Charles Schwab
California
$4.28M +$178K +10,109 +2%
Northern Trust
31
Northern Trust
Illinois
$3.84M +$388K +22,004 +6%
Citadel Advisors
32
Citadel Advisors
Florida
$3.79M -$11.8M -671,146 -65%
Jane Street
33
Jane Street
New York
$3.77M +$5.28M +299,358 +444%
SCM
34
Sio Capital Management
New York
$3.5M +$6M +340,000 New
Coatue Management
35
Coatue Management
New York
$3.13M -$4.3M -243,496 -44%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$2.78M -$759K -43,012 -14%
N
37
Nuveen
North Carolina
$2.66M +$1.6M +90,624 +54%
Squarepoint
38
Squarepoint
New York
$2.19M +$1.04M +58,654 +38%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.94M +$63.5K +3,600 +2%
Franklin Resources
40
Franklin Resources
California
$1.9M -$28.2K -1,598 -0.9%
HF
41
HRT Financial
New York
$1.87M +$2.15M +121,545 +201%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$1.81M +$2.04M +115,358 +190%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.44M -$440K -24,947 -15%
IBT
44
International Biotechnology Trust
United Kingdom
$1.36M
XT
45
XTX Topco
Cayman Islands
$1.29M +$2M +113,341 +908%
SG Americas Securities
46
SG Americas Securities
New York
$1.28M +$1.63M +92,364 +289%
PAMS
47
Pictet Asset Management (Switzerland)
Switzerland
$1.28M +$732K +41,506 +50%
FA
48
Faithward Advisors
Pennsylvania
$1.27M +$141K +7,972 +7%
BBVA
49
Banco Bilbao Vizcaya Argentaria
Spain
$1.15M +$106K +6,014 +6%
Walleye Capital
50
Walleye Capital
New York
$1.13M +$606K +34,335 +46%

NVAX Hedge Fund Activity: Q4 2022 in Review

252 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2022, worth a combined $540M — down 18% from $657M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new NVAX positions and 44 closed out — a net gain of 2 holders — while 79 added to existing stakes and 64 trimmed.

The largest buyer was State Street, adding an estimated $42.7M. The largest seller was Citadel Advisors, cutting an estimated $11.8M.

  • 252 institutional investors held Novavax (NVAX) as of Q4 2022, down from 253 in Q3 2022.
  • Funds reported $540M of Novavax stock for Q4 2022, down 18% quarter-over-quarter.
  • 46 funds opened new Novavax positions in Q4 2022 and 44 closed out, a net change of +2 holders.
  • The largest Novavax buyer in Q4 2022 was State Street, an estimated $42.7M added.
  • The largest Novavax seller in Q4 2022 was Citadel Advisors, an estimated $11.8M sold.

Based on aggregated 13F filings for Q4 2022.